You just read:

Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology

News provided by

Halozyme Therapeutics, Inc.

Jul 19, 2019, 07:00 ET